Tags

Type your tag names separated by a space and hit enter

Silencing of immune activation with methotrexate in patients with COVID-19.
J Neurol Sci. 2020 08 15; 415:116942.JN

Authors+Show Affiliations

Section of Infections of the Nervous System, National Institute of Neurological Disorders and stroke, National Institutes of Health, Bethesda, MD, United States of America.Section of Infections of the Nervous System, National Institute of Neurological Disorders and stroke, National Institutes of Health, Bethesda, MD, United States of America. Electronic address: natha@ninds.nih.gov.

Pub Type(s)

Editorial
Research Support, N.I.H., Intramural

Language

eng

PubMed ID

32471659

Citation

Safavi, Farinaz, and Avindra Nath. "Silencing of Immune Activation With Methotrexate in Patients With COVID-19." Journal of the Neurological Sciences, vol. 415, 2020, p. 116942.
Safavi F, Nath A. Silencing of immune activation with methotrexate in patients with COVID-19. J Neurol Sci. 2020;415:116942.
Safavi, F., & Nath, A. (2020). Silencing of immune activation with methotrexate in patients with COVID-19. Journal of the Neurological Sciences, 415, 116942. https://doi.org/10.1016/j.jns.2020.116942
Safavi F, Nath A. Silencing of Immune Activation With Methotrexate in Patients With COVID-19. J Neurol Sci. 2020 08 15;415:116942. PubMed PMID: 32471659.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Silencing of immune activation with methotrexate in patients with COVID-19. AU - Safavi,Farinaz, AU - Nath,Avindra, Y1 - 2020/05/25/ PY - 2020/05/17/received PY - 2020/05/21/accepted PY - 2020/5/31/pubmed PY - 2020/7/28/medline PY - 2020/5/31/entrez SP - 116942 EP - 116942 JF - Journal of the neurological sciences JO - J Neurol Sci VL - 415 SN - 1878-5883 UR - https://www.unboundmedicine.com/medline/citation/32471659/Silencing_of_immune_activation_with_methotrexate_in_patients_with_COVID_19_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0022-510X(20)30279-3 DB - PRIME DP - Unbound Medicine ER -